1017 studies found for:    "Hodgkin Disease"
Show Display Options
Rank Status Study
21 Unknown  Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Condition: Hodgkin Disease
Interventions: Drug: Combined chemotherapy (ABVD, BACOPP-D);   Procedure: Radiation therapy
22 Recruiting Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: gemcitabine hydrochloride;   Drug: bendamustine hydrochloride
23 Recruiting A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: panobinostat;   Drug: lenalidomide
24 Active, not recruiting Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
Conditions: Childhood Lymphocyte Predominant Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Procedure: conventional surgery;   Drug: cyclophosphamide;   Drug: prednisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
25 Unknown  Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
26 Recruiting Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Conditions: Lymphoma, Non-Hodgkin;   Hodgkin's Disease
Intervention:
27 Completed Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)
Condition: Advanced Hodgkin Disease
Intervention: Drug: COPPEBVCAD vs BEACOPP vs ABVD
28 Active, not recruiting Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Condition: Hodgkin's Disease
Intervention: Procedure: Echocardiogram Stress Test
29 Recruiting Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
Conditions: Hodgkin Disease;   Lymphoma, Non-Hodgkin
Intervention: Other: Database
30 Completed Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Conditions: Breast Cancer;   Hodgkin's Disease
Interventions: Procedure: breast MRI;   Procedure: Mammogram
31 Terminated Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
Condition: Hodgkin Disease
Interventions: Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Prednisone
32 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
33 Completed
Has Results
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Childhood Lymphocyte Depletion Hodgkin Lymphoma;   Childhood Lymphocyte Predominant Hodgkin Lymphoma;   Childhood Mixed Cellularity Hodgkin Lymphoma;   Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Childhood Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Drug: ifosfamide;   Drug: bortezomib;   Drug: vinorelbine tartrate;   Biological: filgrastim
34 Active, not recruiting Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
Conditions: Tumors;   Hodgkins Disease;   Non-Hodgkins Lymphoma
Intervention: Drug: VLI
35 Completed
Has Results
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Conditions: Multiple Myeloma;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Drug: TG-0054 (2.24 mg/kg);   Drug: TG-0054 (3.14 mg/kg)
36 Recruiting PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Conditions: Multiple Myeloma;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Intervention: Drug: TG-0054 combined with G-CSF
37 Active, not recruiting Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
Conditions: Childhood Favorable Prognosis Hodgkin Lymphoma;   Childhood Lymphocyte Depletion Hodgkin Lymphoma;   Childhood Mixed Cellularity Hodgkin Lymphoma;   Childhood Nodular Sclerosis Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma
Interventions: Radiation: radiation therapy;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: prednisone;   Drug: cyclophosphamide;   Drug: ifosfamide;   Drug: vinorelbine tartrate;   Drug: dexamethasone;   Drug: etoposide phosphate;   Drug: cisplatin;   Drug: cytarabine;   Biological: filgrastim
38 Recruiting A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Condition: Hodgkin Disease
Interventions: Drug: brentuximab vedotin;   Drug: bendamustine;   Drug: dacarbazine
39 Terminated Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Bortezomib;   Drug: Dexamethasone
40 Active, not recruiting Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: brentuximab vedotin;   Drug: bendamustine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years